share_log

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Dogan Timur

4/A：持股變動聲明(修正)-高管 Dogan Timur
美股SEC公告 ·  10/10 01:21

牛牛AI助理已提取核心訊息

Timur Dogan, Chief Technology Officer of Cardio Diagnostics Holdings, Inc. (CDIO), completed a purchase of 68,965 shares of common stock on September 6, 2024. The transaction was carried out on the open market at a price of $0.29 per share, resulting in a total investment of $19,999.85. Following this acquisition, Dogan's direct holdings in the company increased to 197,310 shares of common stock.
Timur Dogan, Chief Technology Officer of Cardio Diagnostics Holdings, Inc. (CDIO), completed a purchase of 68,965 shares of common stock on September 6, 2024. The transaction was carried out on the open market at a price of $0.29 per share, resulting in a total investment of $19,999.85. Following this acquisition, Dogan's direct holdings in the company increased to 197,310 shares of common stock.
Timur Dogan，心血管診斷控股公司（CDIO）首席技術官，於2024年9月6日完成了購買68965股普通股的交易。該交易在開放市場以每股0.29美元的價格進行，總投資額爲19999.85美元。在此次收購之後，Dogan在公司的直接持股增加到了197310股普通股。
Timur Dogan，心血管診斷控股公司（CDIO）首席技術官，於2024年9月6日完成了購買68965股普通股的交易。該交易在開放市場以每股0.29美元的價格進行，總投資額爲19999.85美元。在此次收購之後，Dogan在公司的直接持股增加到了197310股普通股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間